#DKK1

Overcoming antigen tolerance to develop GB22–45-2, an anti-DKK1 antibody for gastric cancer Statement of Significance This study presents GB22–45-2, a novel anti-DKK1 monoclonal antibody with comparable anti-tumor activity and better specificity t

Antibody Therapeutics(IF=4.5, Oxford University Press)
Overcoming antigen tolerance to develop GB22–45-2, an anti-DKK1 antibody for gastric cancer
academic.oup.com/abt/article/...
#Antibody #DKK1